State CO
Clinical Trials in Colorado
Recruiting clinical trials with at least one study location in Colorado. Data updated daily from ClinicalTrials.gov.
Top Conditions in Colorado
NCT06446479 Phase 2
Recruiting
Effects of THC on Alcohol Consumption and Neural Correlates of Reward
Condition
Cannabis Use Disorder
Enrollment
28 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevu...
Condition
Dravet Syndrome
Enrollment
170 pts
Location
United States, Japan, United Kingdom
Sponsor
Stoke Therapeutics, Inc
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06345690 N/A
Recruiting
VIA Disc NP Registry 3.0
Condition
Discogenic Pain
Enrollment
500 pts
Location
United States
Sponsor
VIVEX Biologics, Inc.
NCT07096843 Phase 2
Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Condition
Primary Membranous Nephropathy
Enrollment
45 pts
Location
United States, Argentina, Brazil
Sponsor
Climb Bio, Inc.
NCT05440708 Phase 1, Phase 2
Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locall...
Condition
Hepatocellular Carcinoma
Enrollment
178 pts
Location
United States
Sponsor
Tvardi Therapeutics, Incorpora
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Japan
Sponsor
Sanofi
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05033990 N/A
Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE)
Condition
COPD, Early-Onset
Enrollment
1,000 pts
Location
United States
Sponsor
University of Massachusetts, W
NCT07007559 Phase 1, Phase 2
Recruiting
ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Adv...
Condition
Breast Cancer, Metastatic
Enrollment
80 pts
Location
United States
Sponsor
ALX Oncology Inc.
NCT06225596 Phase 2, Phase 3
Recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial ...
Condition
Metastatic Urothelial Cancer
Enrollment
956 pts
Location
United States, Argentina, Australia
Sponsor
BicycleTx Limited
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05974553 N/A
Recruiting
Dialectical Behavior Therapy for Justice-Involved Veterans
Condition
Criminal Behavior
Enrollment
200 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT03717441 N/A
Recruiting
DNA Analysis of Discarded Media Drops From the Clinical IVF Cycles
Condition
Infertility
Enrollment
250 pts
Location
United States
Sponsor
Colorado Center for Reproducti
NCT07033195 N/A
Recruiting
Virtual Reality Treatment for Adults With Chronic Back Pain (VRNT)
Condition
Chronic Pain
Enrollment
200 pts
Location
United States
Sponsor
CognifiSense Inc.
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT04038502 Phase 2
Recruiting
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Condition
Metastatic Castrate Resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
NCT05237141 Phase 4
Recruiting
Etonogestrel Implant as Emergency Contraception
Condition
Contraception
Enrollment
12 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT06448754 Phase 2
Recruiting
Volrustomig Priming Regimens Exploratory Phase II Platform Study
Condition
Non-small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT06345781 N/A
Recruiting
Abdominal Functional Electrical Stimulation to Improve Bowel Function in Spinal ...
Condition
Spinal Cord Injuries
Enrollment
15 pts
Location
United States
Sponsor
Craig Hospital
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology